SCHEMBL1031859

SCHEMBL1031859

CCC(c1ccccc1)N(O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
TRPM8 Q7Z2W7 1/20 0.46
AOC3 Q16853 3/20 0.44
HTR2A P28223 2/20 0.41
HRH1 P35367 2/20 0.41
HKDC1 Q2TB90 1/20 0.41
TRPA1 O75762 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
NOS3 P29474 1/20 0.40
NOS2 P35228 1/20 0.40
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
ALOX5 P09917 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
MIF P14174 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8576434 0.86 LMNA (0.52) LMNATRPM8AOC3HTR2AHRH1
SCHEMBL11141579 0.81 LMNA (0.47) LMNATRPM8AOC3HTR2AHRH1
SCHEMBL13655556 0.79 LMNA (0.45) LMNATRPM8AOC3HTR2AHRH1
SCHEMBL1952126 0.79 TRPM8 (0.49) LMNATRPM8AOC3POLBMEN1
SCHEMBL119104 0.79 HTR2A (0.48) LMNATRPM8AOC3HTR2AHRH1
SCHEMBL8926699 0.79 HTR2A (0.48) LMNATRPM8AOC3HTR2AHRH1
SCHEMBL171013 0.79 HTR2A (0.48) LMNATRPM8AOC3HTR2AHRH1
SCHEMBL6176307 0.78 MMP2 (0.46) LMNATRPM8AOC3POLBMEN1
Iodide SCHEMBL10962372 0.77 HTR2A (0.46) LMNATRPM8AOC3HTR2AHRH1
Hydrochloric Acid SCHEMBL18378384 0.77 TDP1 (0.50) LMNATRPM8AOC3HTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109343-A1 CORROSION INHIBITOR INNOSPEC LIMITED (GB) 2025-04-03 US disclosed
WO-2024231684-A1 USE, METHOD AND DISHWASHING COMPOSITION FOR PREVENTING OR REDUCING CORROSION AND/OR STAINING OF A METALLIC SURFACE IN A CLEANING PROCESS INNOSPEC LIMITED (GB) 2024-11-14 WO disclosed
EP-4460592-A1 CORROSION INHIBITOR Innospec Limited (GB) 2024-11-13 EP disclosed
WO-2023131780-A1 CORROSION INHIBITOR INNOSPEC LIMITED (GB) 2023-07-13 WO disclosed
CN-112226226-B Aniline compound and polyether surfactant composition and poly-surface oil displacement agent 中国石油化工股份有限公司 2023-07-04 CN disclosed
CN-113930229-B Oil displacement agent containing quaternary ammonium salt surfactant composition, and preparation method and application thereof 中国石油化工股份有限公司 2023-05-02 CN disclosed
CN-112694880-B Surfactant composition containing aniline compound for oil displacement, and preparation method and application thereof 中国石油化工股份有限公司 2023-05-02 CN disclosed
EP-2960907-B1 METHOD FOR REMOVING RADIOACTIVE CESIUM, HYDROPHILIC RESIN COMPOSITION FOR REMOVAL OF RADIOACTIVE CESIUM, METHOD FOR REMOVING RADIOACTIVE IODINE AND RADIOACTIVE CESIUM, AND HYDROPHILIC RESIN COMPOSITION FOR REMOVAL OF RADIOACTIVE IODINE AND RADIOACTIVE CESIUM DAINICHISEIKA COLOR CHEM (JP) 2018-12-12 EP disclosed
US-10008300-B2 Method for eliminating radioactive iodine and hydrophilic resin for eliminating radioactive iodine DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) 2018-06-26 US disclosed
US-20180151264-A1 METHOD FOR ELIMINATING RADIOACTIVE IODINE AND HYDROPHILIC RESIN FOR ELIMINATING RADIOACTIVE IODINE UKIMA CHEMICALS & COLOR MFG. CO., LTD. (JP) 2018-05-31 US disclosed
US-7425567-B2 Piperidine derivative compounds and drugs containing the compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-09-16 US disclosed
US-20050080107-A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-04-14 US disclosed
EP-1481969-A1 PIPERIDINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2004-12-01 EP disclosed
EP-0930172-B1 Ink-jet recording sheet and process for the production of the sheet DAINICHISEIKA COLOR CHEM (JP) 2004-08-25 EP disclosed
EP-0925955-B1 Ink-jet recording sheet and coating formulation for the production of the sheet DAINICHISEIKA COLOR CHEM (JP) 2004-01-02 EP disclosed
US-6358306-B1 Ink-jet recording sheet and coating formulation for the production of the sheet DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) 2002-03-19 US disclosed
US-6143419-A Ink-jet recording sheet comprising a molecule containing tertiary amino groups and polysiloxane segments DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) 2000-11-07 US disclosed
US-6117552-A AN INK-RECEIVING COATINGS COMPRISES A HYDROPHILIC RESIN CONTAINING HYDROLYZABLE SILYL GROUPS IN A MOLECULE, AND ONE OR MORE INORGANIC AND ORGANIC PIGMENTS, AND RESIN PARTICLES; IMPROVED ABSORBENCY, FIXABILITY, BLOCKING RESISTANCE DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) 2000-09-12 US disclosed
EP-0930172-A1 Ink-jet recording sheet and coating formulation for the production of the sheet DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) 1999-07-21 EP disclosed
EP-0925955-A1 Ink-jet recording sheet and coating formulation for the production of the sheet DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080107-A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient PDCD4, PDE4B, IRAK4 LMNA 2698/4885TRPM8 3563/4885AOC3 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.